- call +1-201-465-4211
- email sales@mrinsights.biz
Angina is a type of chest pain caused by reduced blood flow to the heart. Angina (an-JIE-nuh or AN-juh-nuh) is a symptom of coronary artery disease. Angina, which may also be called angina pectoris, is often described as squeezing, pressure, heaviness, tightness or pain in your chest
Scope of the Report:
The worldwide market for Angina is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Angina in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Amgen
Taxus Cardium Pharmaceuticals
LegoChem Biosciences
Lee’s Pharmaceutical
Milestone Pharmaceuticals
Juventas Therapeutics
ViroMed
Kuhnil Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Beta Blockers
Calcium Antagonists
Anticoagulants
Antiplatelet
Nitrates
ACE inhibitors
Ranolazine
Market Segment by Applications, can be divided into
Clinics
Hospitals
Other
There are 15 Chapters to deeply display the global Angina market.
Chapter 1, to describe Angina Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Angina, with sales, revenue, and price of Angina, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Angina, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Angina market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Angina sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Angina Introduction
1.2 Market Analysis by Type
1.2.1 Beta Blockers
1.2.2 Calcium Antagonists
1.2.3 Anticoagulants
1.2.4 Antiplatelet
1.2.5 Nitrates
1.2.6 ACE inhibitors
1.2.7 Ranolazine
1.3 Market Analysis by Applications
1.3.1 Clinics
1.3.2 Hospitals
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Angina Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Angina Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Taxus Cardium Pharmaceuticals
2.2.1 Business Overview
2.2.2 Angina Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Taxus Cardium Pharmaceuticals Angina Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 LegoChem Biosciences
2.3.1 Business Overview
2.3.2 Angina Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 LegoChem Biosciences Angina Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Lee’s Pharmaceutical
2.4.1 Business Overview
2.4.2 Angina Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Lee’s Pharmaceutical Angina Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Milestone Pharmaceuticals
2.5.1 Business Overview
2.5.2 Angina Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Milestone Pharmaceuticals Angina Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Juventas Therapeutics
2.6.1 Business Overview
2.6.2 Angina Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Juventas Therapeutics Angina Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 ViroMed
2.7.1 Business Overview
2.7.2 Angina Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 ViroMed Angina Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Kuhnil Pharmaceutical
2.8.1 Business Overview
2.8.2 Angina Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Kuhnil Pharmaceutical Angina Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Angina Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Angina Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Angina Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Angina Manufacturer Market Share in 2017
3.3.2 Top 6 Angina Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Angina Market Analysis by Regions
4.1 Global Angina Sales, Revenue and Market Share by Regions
4.1.1 Global Angina Sales and Market Share by Regions (2013-2018)
4.1.2 Global Angina Revenue and Market Share by Regions (2013-2018)
4.2 North America Angina Sales and Growth Rate (2013-2018)
4.3 Europe Angina Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Angina Sales and Growth Rate (2013-2018)
4.5 South America Angina Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Angina Sales and Growth Rate (2013-2018)
5 North America Angina by Countries
5.1 North America Angina Sales, Revenue and Market Share by Countries
5.1.1 North America Angina Sales and Market Share by Countries (2013-2018)
5.1.2 North America Angina Revenue and Market Share by Countries (2013-2018)
5.2 United States Angina Sales and Growth Rate (2013-2018)
5.3 Canada Angina Sales and Growth Rate (2013-2018)
5.4 Mexico Angina Sales and Growth Rate (2013-2018)
6 Europe Angina by Countries
6.1 Europe Angina Sales, Revenue and Market Share by Countries
6.1.1 Europe Angina Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Angina Revenue and Market Share by Countries (2013-2018)
6.2 Germany Angina Sales and Growth Rate (2013-2018)
6.3 UK Angina Sales and Growth Rate (2013-2018)
6.4 France Angina Sales and Growth Rate (2013-2018)
6.5 Russia Angina Sales and Growth Rate (2013-2018)
6.6 Italy Angina Sales and Growth Rate (2013-2018)
7 Asia-Pacific Angina by Countries
7.1 Asia-Pacific Angina Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Angina Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Angina Revenue and Market Share by Countries (2013-2018)
7.2 China Angina Sales and Growth Rate (2013-2018)
7.3 Japan Angina Sales and Growth Rate (2013-2018)
7.4 Korea Angina Sales and Growth Rate (2013-2018)
7.5 India Angina Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Angina Sales and Growth Rate (2013-2018)
8 South America Angina by Countries
8.1 South America Angina Sales, Revenue and Market Share by Countries
8.1.1 South America Angina Sales and Market Share by Countries (2013-2018)
8.1.2 South America Angina Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Angina Sales and Growth Rate (2013-2018)
8.3 Argentina Angina Sales and Growth Rate (2013-2018)
8.4 Colombia Angina Sales and Growth Rate (2013-2018)
9 Middle East and Africa Angina by Countries
9.1 Middle East and Africa Angina Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Angina Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Angina Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Angina Sales and Growth Rate (2013-2018)
9.3 UAE Angina Sales and Growth Rate (2013-2018)
9.4 Egypt Angina Sales and Growth Rate (2013-2018)
9.5 Nigeria Angina Sales and Growth Rate (2013-2018)
9.6 South Africa Angina Sales and Growth Rate (2013-2018)
10 Global Angina Market Segment by Type
10.1 Global Angina Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Angina Sales and Market Share by Type (2013-2018)
10.1.2 Global Angina Revenue and Market Share by Type (2013-2018)
10.2 Beta Blockers Sales Growth and Price
10.2.1 Global Beta Blockers Sales Growth (2013-2018)
10.2.2 Global Beta Blockers Price (2013-2018)
10.3 Calcium Antagonists Sales Growth and Price
10.3.1 Global Calcium Antagonists Sales Growth (2013-2018)
10.3.2 Global Calcium Antagonists Price (2013-2018)
10.4 Anticoagulants Sales Growth and Price
10.4.1 Global Anticoagulants Sales Growth (2013-2018)
10.4.2 Global Anticoagulants Price (2013-2018)
10.5 Antiplatelet Sales Growth and Price
10.5.1 Global Antiplatelet Sales Growth (2013-2018)
10.5.2 Global Antiplatelet Price (2013-2018)
10.6 Nitrates Sales Growth and Price
10.6.1 Global Nitrates Sales Growth (2013-2018)
10.6.2 Global Nitrates Price (2013-2018)
10.7 ACE inhibitors Sales Growth and Price
10.7.1 Global ACE inhibitors Sales Growth (2013-2018)
10.7.2 Global ACE inhibitors Price (2013-2018)
10.8 Ranolazine Sales Growth and Price
10.8.1 Global Ranolazine Sales Growth (2013-2018)
10.8.2 Global Ranolazine Price (2013-2018)
11 Global Angina Market Segment by Application
11.1 Global Angina Sales Market Share by Application (2013-2018)
11.2 Clinics Sales Growth (2013-2018)
11.3 Hospitals Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 Angina Market Forecast (2018-2023)
12.1 Global Angina Sales, Revenue and Growth Rate (2018-2023)
12.2 Angina Market Forecast by Regions (2018-2023)
12.2.1 North America Angina Market Forecast (2018-2023)
12.2.2 Europe Angina Market Forecast (2018-2023)
12.2.3 Asia-Pacific Angina Market Forecast (2018-2023)
12.2.4 South America Angina Market Forecast (2018-2023)
12.2.5 Middle East and Africa Angina Market Forecast (2018-2023)
12.3 Angina Market Forecast by Type (2018-2023)
12.3.1 Global Angina Sales Forecast by Type (2018-2023)
12.3.2 Global Angina Market Share Forecast by Type (2018-2023)
12.4 Angina Market Forecast by Application (2018-2023)
12.4.1 Global Angina Sales Forecast by Application (2018-2023)
12.4.2 Global Angina Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Angina Picture
Table Product Specifications of Angina
Figure Global Sales Market Share of Angina by Types in 2017
Table Angina Types for Major Manufactu
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
